China’s First Judicial Decision on Patent Linkage

Jun 9, 2022
| By Fang Qi and Danlei Wu
The Beijing Intellectual Property Court recently issued the first-ever decision in a dispute between a brand-name and a generic drug company under China’s newly-created patent linkage regime. Fang Qi and Danlei Wu of Fangda Partners examine the decision and its implications

Thank you for sharing!

Your article was successfully shared with the contacts you provided.


This premium content is reserved for
China Law & Practice Subscribers.

A Premium Subscription Provides:

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment

Subscribe Now

For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected].